Not All Women Who Are Clinically High-Risk Benefit from Extended Endocrine Therapy

Download video

Not All Women Who Are Clinically High-Risk Benefit from Extended Endocrine Therapy

154 views

Breast Cancer Index

6 days ago

Not All Women Who Are Clinically High-Risk Benefit from Extended Endocrine Therapy

5:44

GOOGLE AI Discovers New Cancer Therapy Pathway! | Cell2Sentence-Scale 27B

by HEALTH ON SCREEN

25:46

PARP Inhibitors with Sharyn N Lewin Sept 25 2025

by Woman to Woman Program

$The \\$

9:51

The \\"Woman's\\" Role Is Vital, But... ((( 2 STRONG )))

by Both Sides

$Limitations and potential of Phase II PATRICIA trial in HER2+\/HR+ advanced breast cancer$

0:48

Limitations and potential of Phase II PATRICIA trial in HER2+\/HR+ advanced breast cancer

by VJOncology

3:57

Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced breast cancer compared...

by ecancer

9:58

7 sai lầm khiến nội tiết tố suy giảm nhanh, 90% phụ nữ đều mắc

by Sức khỏe tuổi 50+

1:11:10

Lecture 02.1: Introduction to Next-Generation Sequencing and its clinical applications (part 2)

by Advanced VnPathoinformatics

3:33

Get to feeling better with a total hormone checkup from U.S. Women’s Medical Center

by FOX 2 St. Louis

$Chronic Illness, Hormones \& Women's Issues. It's All In Your Head!$

39:16

Chronic Illness, Hormones \& Women's Issues. It's All In Your Head!

by 2OF Entertainment Channel

4:13

And can even give you hypertension! #02

by Tùng Nguyễn

0:57

Emerging HER2-targeting ADCs in bladder cancer

by VJOncology

8:13

2 phụ nữ ngoài 30 đột quỵ, cảnh báo nguy cơ tiềm ẩn ở người trẻ | SKĐS

by Báo Sức khỏe \& Đời sống

$Updated safety findings of PF-07220060 and endocrine therapy in HR+\/HER2- breast cancer$

1:20

Updated safety findings of PF-07220060 and endocrine therapy in HR+\/HER2- breast cancer

by VJOncology

5:54

AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers

by ecancer

23:15

Medicare Supplement Hidden Risks Part 02

by MedigapSeminars.org

10:52

【Key Message】Early Optimal Control of Glycemia Level is Crucial in Preventing T2D Complications

by P2PMD

$Endocrine Therapies in ER-Positive\/HER2-Negative MBC: Understanding Their Benefits and Limitation...$

31:51

Endocrine Therapies in ER-Positive\/HER2-Negative MBC: Understanding Their Benefits and Limitation...

by Medscape

Best on Vidoe

Not All Women Who Are Clinically High-Risk Benefit from Extended Endocrine Therapy